12/2
03:47 pm
vcyt
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
06:03 pm
vcyt
Veracyte (NASDAQ:VCYT) was given a new $48.00 price target on by analysts at Morgan Stanley.
Low
Report
Veracyte (NASDAQ:VCYT) was given a new $48.00 price target on by analysts at Morgan Stanley.
11/26
02:23 pm
vcyt
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
01:40 pm
vcyt
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/16
01:10 am
vcyt
Low
Report
11/14
01:19 pm
vcyt
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Veracyte (NASDAQ:VCYT) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
11/11
12:21 pm
vcyt
Veracyte (NASDAQ:VCYT) had its price target raised by analysts at Morgan Stanley from $28.00 to $40.00. They now have an "underweight" rating on the stock.
Low
Report
Veracyte (NASDAQ:VCYT) had its price target raised by analysts at Morgan Stanley from $28.00 to $40.00. They now have an "underweight" rating on the stock.
11/11
09:21 am
vcyt
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up [Yahoo! Finance]
Low
Report
VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up [Yahoo! Finance]
11/9
01:13 am
vcyt
Veracyte (NASDAQ:VCYT) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c)" rating.
Low
Report
Veracyte (NASDAQ:VCYT) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c)" rating.
11/6
08:30 am
vcyt
Veracyte to Participate in Upcoming Investor Conferences
High
Report
Veracyte to Participate in Upcoming Investor Conferences
11/5
10:06 am
vcyt
Veracyte (NASDAQ:VCYT) had its price target raised by analysts at Guggenheim from $40.00 to $45.00. They now have a "buy" rating on the stock.
Medium
Report
Veracyte (NASDAQ:VCYT) had its price target raised by analysts at Guggenheim from $40.00 to $45.00. They now have a "buy" rating on the stock.
11/5
10:03 am
vcyt
Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/5
07:19 am
vcyt
Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
High
Report
Veracyte (NASDAQ:VCYT) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
11/5
04:03 am
vcyt
Veracyte (NASDAQ:VCYT) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Medium
Report
Veracyte (NASDAQ:VCYT) had its "hold" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
11/4
11:48 pm
vcyt
Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/4
04:05 pm
vcyt
Veracyte Announces Third Quarter 2025 Financial Results
High
Report
Veracyte Announces Third Quarter 2025 Financial Results
11/3
04:15 pm
vcyt
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Low
Report
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
10/20
07:20 am
vcyt
Veracyte (NASDAQ:VCYT) was given a new $40.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Veracyte (NASDAQ:VCYT) was given a new $40.00 price target on by analysts at Canaccord Genuity Group Inc..
10/18
08:33 am
vcyt
How the Narrative Around Veracyte Is Evolving With Recent Analyst Updates and Pipeline Progress [Yahoo! Finance]
Medium
Report
How the Narrative Around Veracyte Is Evolving With Recent Analyst Updates and Pipeline Progress [Yahoo! Finance]
10/18
07:39 am
vcyt
Is Veracyte's (VCYT) Margin Growth and New Platform Shaping Its Long-Term Diagnostic Edge? [Yahoo! Finance]
Medium
Report
Is Veracyte's (VCYT) Margin Growth and New Platform Shaping Its Long-Term Diagnostic Edge? [Yahoo! Finance]
10/15
05:31 pm
vcyt
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
Medium
Report
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
10/8
07:29 am
vcyt
Veracyte (NASDAQ:VCYT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Veracyte (NASDAQ:VCYT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/6
09:50 am
vcyt
Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher's Clinical Impact [Yahoo! Finance]
Low
Report
Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher's Clinical Impact [Yahoo! Finance]
9/28
04:03 pm
vcyt
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer [Yahoo! Finance]
Low
Report
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer [Yahoo! Finance]
9/28
04:00 pm
vcyt
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Low
Report
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer